Evidence map›Paper›PMID 41162597›Full record

ArticleScientific reports2025

IL-1β alters the virulence of uropathogenic Escherichia coli.

Fatma Kalaycı-Yüksek, Rongrong Wu, Ignacio Rangel, Isak Demirel

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Insulin Affects Biological Behaviours ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatma Kalaycı-YüksekFaculty of Medicine, Department of Medical Microbiology, Istanbul Yeni Yüzyıl University, Istanbul, Turkey.
Rongrong WuSchool of Medical Sciences, Örebro University, Campus USÖ, Örebro, SE-701 82, Sweden.
Ignacio RangelSchool of Medical Sciences, Örebro University, Campus USÖ, Örebro, SE-701 82, Sweden.
Isak DemirelSchool of Medical Sciences, Örebro University, Campus USÖ, Örebro, SE-701 82, Sweden. isak.demirel@oru.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infection (UTI). While the role of UPEC in triggering host immune responses is well studied, less is known about how host-derived cytokines influence UPEC virulence. The aim of this study was to investigate how the pro-inflammatory cytokine IL-1β affects UPEC virulence, metabolism, and host-pathogen interactions. Using the CFT073 strain, we found that IL-1β exposure induced a rapid metabolic shift characterized by decreased oxygen consumption rate (OCR) and increased extracellular acidification rate (ECAR), indicating a transition from respiration to fermentative metabolism. Microarray analysis confirmed the upregulation of fermentative (hyc) and antioxidant (katG, ahpF, grxA) genes, along with increased purine biosynthesis, supporting a metabolic state favouring stress resistance and proliferation. IL-1β also increased fimH and papC gene expression, leading to increased adhesion and invasion of bladder epithelial cells. Furthermore, IL-1β-stimulated CFT073 suppressed the gene expression of several innate immune related genes in a C. elegans infection model. Taken together, our findings suggest that IL-1β induces a virulence-enhancing metabolic change in UPEC, which could enhance its persistence and colonization of the urinary tract. This cross-kingdom signaling may have implications for infection dynamics during a UTI.

Indexed as

Escherichia coli InfectionsInterleukin-1betaUropathogenic Escherichia coliAnimalsCaenorhabditis elegansEscherichia coli ProteinsGene Expression Regulation, BacterialHost-Pathogen InteractionsHumansUrinary Tract InfectionsVirulenceEscherichia coli ProteinsInterleukin-1betaC. elegansColonizationCross-kingdom interactionIL-1βUropathogenic E. coli

Identifiers

PMID41162597
PMCPMC12572196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.